Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Only a few studies mention the existence of tyrosine hydroxylase immunoreactive neurons in the striatum. These neurons are known to be increased following lesion of the dopaminergic nigrostriatal pathway. Recently it has been shown that glial cell line-derived neurotrophic factor treatment was able to increase the number of these neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated primate. Here we report that, in the rat, these neurons are responsive to intrastriatal injection of 6-hydroxydopamine and that following the lesion their number tends to increase with time. Moreover, we have shown that L-DOPA treatment for 2 weeks or nerve growth factor treatment for 8 weeks are able to dramatically augment their number.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neulet.2004.02.068 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!